Canadian Cancer Trials Group Bulletins

General


Dr. Laurence Klotz Awarded O. Harold Warwick Prize

Dr. Laurence Klotz In June 2015, Dr. Laurence Klotz from Sunnybrook Health Sciences Centre in Toronto was awarded the O. Harold Warwick Prize, given to a scientist whose research has had a major impact on cancer control in Canada.

Dr. Klotz is a leading urologic cancer surgeon and research investigator in Canada and worldwide. He is a member of the Canadian Cancer Trials Group's Genitourinary Site Committee and has chaired several Canadian Cancer Trials Group trials, including BL.9, BL.10, RE.1, PR.9 and PR.11. Notably, he was co-chair of PR.7, which found that intermittent androgen deprivation was non-inferior to continuous therapy with respect to overall survival. Additionally, some quality of life factors, including physical function, fatigue, urinary problems, hot flashes, libido, and erectile function improved with intermittent therapy. The results of the trial were presented at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting and was selected to be included in the Best of ASCO. The final results were published in the New England Journal of Medicine in 2012.

The prize, awarded by the Canadian Cancer Society, is named after Dr. Warwick, a pioneering researcher in cancer control and treatment, who became the first executive director of both the former National Cancer Institute of Canada and the Canadian Cancer Society.

You can read more about Dr. Klotz and the award by using this link ... http://www.cancer.ca/en/about-us/our-research/awards/?region=on.

On behalf of the Canadian Cancer Trials Group, we would like to extend our congratulations to Dr. Klotz!